Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and colorectal cancer prevention platelet hypothesis study
2013-004269-15Phase 3Active
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- Mar 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aspirin in colorectal cancer (CRC), sponsored by Instituto Aragonés de Ciencias de la Salud. Primary endpoint: COX-1 acetylation at 24 hours after dosing. Started Mar 2014; status: active.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2013-004269-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004269-15.